Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-03-11
2010-10-19
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S242000
Reexamination Certificate
active
07816363
ABSTRACT:
This invention comprises the novel compounds of formula (I) wherein n, t, R1, R2, R3, R4, L, Q, X, Y, Z and have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine.
REFERENCES:
patent: 2005/0096468 (2005-05-01), Van Emelen et al.
patent: 0188094 (1985-12-01), None
patent: 0827742 (1998-03-01), None
patent: WO 98/55449 (1998-12-01), None
patent: WO 00/52001 (2000-09-01), None
patent: WO 01/38322 (2001-05-01), None
patent: WO 01/70875 (2001-09-01), None
patent: WO 03/011851 (2003-02-01), None
Finnin et al., “Structures of histone deacetylase homologue bound to the TSA and SAHA inhibitors,”Nature, 1999, pp. 188-193, vol. 401.
PCT International Search Report mailed Aug. 13, 2003 for PCT Application No. PCT/EP03/02514 which relates to U.S. Patent Application filed herewith.
Angibaud Patrick Rene
Dyatkin Alexey Borisovich
Pilatte Isabelle Noëlle Constance
Roux Bruno
Van Brandt Sven Franciscus Anna
Janssen Pharmaceutica N.V.
Leeser Erich A
Wilson James O
LandOfFree
Inhibitors of histone deacetylase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of histone deacetylase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of histone deacetylase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4198995